These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 27480514)
41. Successful inhibition of allergic contact dermatitis caused by methylchloroisothiazolinone/methylisothiazolinone with topical glutathione. Isaksson M Contact Dermatitis; 2015 Aug; 73(2):126-8. PubMed ID: 25891419 [No Abstract] [Full Text] [Related]
42. Acquired port-wine stains in six pediatric patients. Stephens MR; Putterman E; Yan AC; Castelo-Soccio L; Perman MJ Pediatr Dermatol; 2020 Jan; 37(1):93-97. PubMed ID: 31631390 [TBL] [Abstract][Full Text] [Related]
43. Treatment of port wine stains with pulsed dye laser and topical timolol: a multicenter randomized controlled trial. Passeron T; Maza A; Fontas E; Toubel G; Vabres P; Livideanu C; Mazer JM; Rossi B; Boukari F; Harmelin Y; Dreyfus I; Mazereeuw-Hautier J; Lacour JP Br J Dermatol; 2014 Jun; 170(6):1350-3. PubMed ID: 24641096 [TBL] [Abstract][Full Text] [Related]
44. Allergic contact dermatitis to topical preparations of bufexamac. Pan Y; Nixon R Australas J Dermatol; 2012 Aug; 53(3):207-10. PubMed ID: 22881467 [TBL] [Abstract][Full Text] [Related]
45. Recurrent oral pyogenic granuloma in port-wine stain. da Silva AD; Silva CA; de Camargo Moraes P; Thomaz LA; Furuse C; de Araújo VC J Craniofac Surg; 2011 Nov; 22(6):2356-8. PubMed ID: 22134277 [TBL] [Abstract][Full Text] [Related]
46. Are port wines stains a feature of tuberous sclerosis? Ben-Amitai D; Halachmi S; Lapidoth M J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):804-7. PubMed ID: 20946584 [TBL] [Abstract][Full Text] [Related]
47. Port wine stains: laser treatment and nursing management. Walker PS Br J Nurs; 1996 Nov 14-27; 5(20):1235-40. PubMed ID: 9004560 [TBL] [Abstract][Full Text] [Related]
48. Treatment of port wine stains. Goldberg DJ J Cosmet Laser Ther; 2010 Feb; 12(1):1. PubMed ID: 20085449 [No Abstract] [Full Text] [Related]
49. Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment. Huikeshoven M; Koster PH; de Borgie CA; Beek JF; van Gemert MJ; van der Horst CM N Engl J Med; 2007 Mar; 356(12):1235-40. PubMed ID: 17377161 [TBL] [Abstract][Full Text] [Related]
50. Pyogenic granuloma arising in port-wine stain after cryotherapy. Aghaei S Dermatol Online J; 2003 Dec; 9(5):16. PubMed ID: 14996389 [TBL] [Abstract][Full Text] [Related]
51. Combined contact and photocontact allergic dermatitis to etofenamate in flogoprofen gel. Sánchez-Pérez J; Sánchez TS; García-Díez A Am J Contact Dermat; 2001 Dec; 12(4):215-6. PubMed ID: 11753896 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of the treatment of port-wine stains with the 595-nm long pulsed dye laser: a large prospective study in adult Japanese patients. Asahina A; Watanabe T; Kishi A; Hattori N; Shirai A; Kagami S; Watanabe R; Le Pavoux A; Maekawa T; Tamaki K; Ohara K J Am Acad Dermatol; 2006 Mar; 54(3):487-93. PubMed ID: 16488301 [TBL] [Abstract][Full Text] [Related]
53. Cryogen spray cooling in conjunction with pulse dye laser treatment of port wine stains of the head and neck. Huang PS; Chang CJ Chang Gung Med J; 2001 Aug; 24(8):469-75. PubMed ID: 11601188 [TBL] [Abstract][Full Text] [Related]
57. Research critique of pulsed dye laser treatment of port-wine stains: a patient questionnaire. Hinojosa RJ Plast Surg Nurs; 1997; 17(3):159-61. PubMed ID: 9393043 [No Abstract] [Full Text] [Related]
58. Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis. Bäumer W; Sülzle B; Weigt H; De Vries VC; Hecht M; Tschernig T; Kietzmann M Br J Dermatol; 2005 Jul; 153(1):136-44. PubMed ID: 16029339 [TBL] [Abstract][Full Text] [Related]
59. Allergic contact dermatitis caused by efinaconazole: positive patch test reactions up to 0.1% pet. Oiso N; Tatebayashi M; Kawada A Contact Dermatitis; 2017 Jan; 76(1):53-54. PubMed ID: 27957750 [No Abstract] [Full Text] [Related]
60. Case of allergic contact dermatitis due to 1,3-butylene glycol. Aizawa A; Ito A; Masui Y; Ito M J Dermatol; 2014 Sep; 41(9):815-6. PubMed ID: 25182293 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]